P1406
Protein A–Agarose
lyophilized powder
Synonym(s):
Protein A resin
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Form:
lyophilized powder
form
lyophilized powder
Quality Level
extent of labeling
~2 mg per mL
matrix
Cross-linked 4% beaded agarose
matrix activation
cyanogen bromide
matrix attachment
amino
matrix spacer
1 atom
capacity
≥15 mg/mL binding capacity (human IgG)
storage temp.
−20°C
Application
Protein A-agarose is used for affinity chromatography, antibody purification and characterization, and protein A, G and L resins. Protein A-agarose has been used to study the effects of protein A immunoadsorption in patients with chronic dilated cardiomyopathy as well as to study multiple sclerosis and gastric cancer. Protein A–Agarose has been used as an immobilized biosensor. It has also been used for immunoprecipitation.
Physical form
Supplied as lyophilized powder stabilized with lactose.
Preparation Note
Swelling: 1 g swells to 3-6 ml
Still not finding the right product?
Explore all of our products under Protein A–Agarose
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Skin Corr. 1B - STOT SE 3
target_organs
Respiratory system
Storage Class
8A - Combustible corrosive hazardous materials
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Access high-quality reagents for antibody workflows, including adjuvants, blocking reagents, conjugation kits, and more.
An integrated solution for rapid biosensing with robust linker free covalent bindingsurfaces
Yin Y, et al.
A Risk-Management Strategy for PCB-Contaminated Sediments (2013)
V A Lightner et al.
The Journal of cell biology, 108(6), 2483-2493 (1989-06-01)
Tenascin/hexabrachion is a large glycoprotein of the extracellular matrix. Previous reports have demonstrated that tenascin is associated with epithelial-mesenchymal interfaces during embryogenesis and is prominent in the matrix of many tumors. However, the distribution of tenascin is more restricted in
P Libby et al.
The American journal of pathology, 124(2), 179-185 (1986-08-01)
Interleukin 1 (IL-1) can induce potentially pathogenic functions of vascular endothelial cells. This mediator was formerly thought to be produced primarily by activated macrophages. We report here that bacterial endotoxin and recombinant human tumor necrosis factor cause accumulation of IL-1